Market revenue in 2023 | USD 234.7 million |
Market revenue in 2030 | USD 305.0 million |
Growth rate | 3.8% (CAGR from 2023 to 2030) |
Largest segment | Coronary stents |
Fastest growing segment | Accessory Devices |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Intravascular Imaging Catheters and Pressure Guidewires, Coronary Stents, PTCA Balloon Catheters, Accessory Devices |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Koninklijke Philips NV, Cardinal Health Inc, Terumo Corp, Teleflex Inc, B. Braun, Biosensors, BIOTRONIK, Asahi Intecc Co Ltd, Cook Medical, Merit Medical Systems Inc, Haemonetics Corp, Vascular Solutions, Zeon Corp, Alvimedica, Meril Life, Medinol |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to interventional cardiology devices market will help companies and investors design strategic landscapes.
Coronary stents was the largest segment with a revenue share of 50.28% in 2023. Horizon Databook has segmented the Middle East & Africa interventional cardiology devices market based on intravascular imaging catheters and pressure guidewires, coronary stents, ptca balloon catheters, accessory devices covering the revenue growth of each sub-segment from 2018 to 2030.
The MEA interventional cardiology devices market is driven by several factors, including the increasing prevalence of CVDs and the growing adoption of minimally invasive procedures. The region has a high burden of CVDs, including conditions that increase the risk of stroke, making interventional cardiology devices a valuable treatment option.
Many hospitals and medical centers are being set up in countries like Saudi Arabia, the UAE, and South Africa, with growing adoption of novel intervention devices. These are used to treat conditions that can increase the risk of stroke if left untreated.
Key companies are actively involved in developing and commercializing novel interventional cardiology devices, aiming to improve patient outcomes and reduce the burden of CVDs in the region.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa interventional cardiology devices market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa interventional cardiology devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account